Diabetic ketoacidosis: Not always due to type 1 diabetes

BMJ (Online)

Volumn 347, Issue 7922, 2013, Pages

  Misra, S ^a   Oliver, N S ^b   Dornhorst, A ^b  

^a CHARING CROSS HOSPITAL   (United Kingdom)

^b IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; BICARBONATE; C PEPTIDE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; KETONE;

BIOCHEMISTRY; CAUSAL ATTRIBUTION; CLINICAL FEATURE; DIABETIC KETOACIDOSIS; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; HYPEROSMOLAR HYPERGLYCEMIC SYNDROME; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; INSULIN TREATMENT; LABORATORY TEST; METABOLIC DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; NOTE; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL FUNCTION; PATHOPHYSIOLOGY; PATIENT MONITORING; PRIORITY JOURNAL;

EID: 84883229060     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.f3501     Document Type: Note

References (22)

1. Drouin P, Blickle JF, Charbonnel B, Eschwege E, Guillausseau PJ, Plouin PF, et al. Diagnosis and classification of diabetes mellitus. Porte D, Sherwin RS, Baron A, eds. Diabetes Care 2009;32(suppl 1):S62-7.
2. Umpierrez GE, Smiley D, Kitabchi AE. Narrative review: ketosis-prone type 2 diabetes mellitus. Ann Intern Med 2006;144:350-7. (Pubitemid 46768192)
3. Laffel L. Ketone bodies: a review of physiology, pathophysiology and application of monitoring to diabetes. Diabetes Metab Res Rev 1999;15:412-26. (Pubitemid 30066228)
4. Umpierrez GE, Woo W, Hagopian WA, Isaacs SD, Palmer JP, Gaur LK, et al. Immunogenetic analysis suggests different pathogenesis for obese and lean African-Americans with diabetic ketoacidosis. Diabetes Care 1999;22:1517-23. (Pubitemid 29418249)
5. Umpierrez GE, Casals MM, Gebhart SP, Mixon PS, Clark WS, Phillips LS. Diabetic ketoacidosis in obese African-Americans. Diabetes 1995;44:790-5.
6. Umpierrez GE. Ketosis-prone type 2 diabetes: time to revise the classification of diabetes. Diabetes Care 2006;29:2755-7. (Pubitemid 44912214)
7. Mauvais-Jarvis F, Smith SB, Le May C, Leal SM, Gautier J-F, Molokhia M, et al. PAX4 gene variations predispose to ketosis-prone diabetes. Hum Mol Genet 2004;13:3151-9. (Pubitemid 40045267)
8. Sobngwi E, Gautier J-F, Kevorkian J-P, Villette J-M, Riveline J-P, Zhang S, et al. High prevalence of glucose-6-phosphate dehydrogenase deficiency without gene mutation suggests a novel genetic mechanism predisposing to ketosis-prone diabetes. J Clin Endocrinol Metab 2005;90:4446-51. (Pubitemid 41159325)
9. Mauvais-Jarvis F, Sobngwi E, Porcher R, Riveline J-P, Kevorkian J-P, Vaisse C, et al. Ketosis-prone type 2 diabetes in patients of sub-Saharan African origin: clinical pathophysiology and natural history of beta-cell dysfunction and insulin resistance. Diabetes 2004;53:645-53. (Pubitemid 38270633)
10. McFarlane SI, Chaiken RL, Hirsch S, Harrington P, Lebovitz HE, Banerji MA. Near-normoglycaemic remission in African-Americans with type 2 diabetes mellitus is associated with recovery of beta cell function. Diabet Med 2001;18:10-6. (Pubitemid 32158102)
11. Choukem S-P, Sobngwi E, Fetita L-S, Boudou P, De Kerviler E, Boirie Y, et al. Multitissue insulin resistance despite near-normoglycemic remission in Africans with ketosis-prone diabetes. Diabetes Care 2008;31:2332-7.
12. Smiley D, Chandra P, Umpierrez GE. Update on diagnosis, pathogenesis and management of ketosis-prone type 2 diabetes mellitus.. Diabetes Manag(Lond) 2011;1:589-600.
13. National Institute for Health and Care Excellence. Type 1 diabetes in adults: full guideline part 2. CG15. 2008. http://guidance.nice.org.uk/CG15/ Guidance/Adults.
14. Maldonado MR, Otiniano ME, Lee R, Rodriguez L, Balasubramanyam A. For the patient. Characteristics of ketosis-prone diabetes in a multiethnic indigent community. Ethnic Dis 2004;14:309.
15. Pinhas-Hamiel O, Dolan LM, Zeitler PS. Diabetic ketoacidosis among obese African-American adolescents with NIDDM. Diabetes Care 1997;20:484-6. (Pubitemid 27143400)
16. Savage MW, Dhatariya KK, Kilvert A, Rayman G, Rees JAE, Courtney CH, et al. Joint British Diabetes Societies guideline for the management of diabetic ketoacidosis. Diabet Med 2011;28:508-15.
17. Balasubramanyam A, Zern JW, Hyman DJ, Pavlik V. New profiles of diabetic ketoacidosis: type 1 vs type 2 diabetes and the effect of ethnicity. Arch Intern Med 1999;159:2317-22. (Pubitemid 29501532)
18. Joint British Diabetes Societies Inpatient Care Group. The management of the hyperosmolar hyperglycaemic state (HHS) in adults with diabetes, 2012. www.diabetes. nhs.uk/news-and-events/nhs-diabetes-issues-new-guidance-on-the- management- of-the-hyperosmolar-hyperglycaemic-state-hhs/#.
19. Umpierrez GE, Clark WS, Steen MT. Sulfonylurea treatment prevents recurrence of hyperglycemia in obese African-American patients with a history of hyperglycemic crises. Diabetes Care 1997;20:479-83. (Pubitemid 27143399)
20. Banerji MA, Chaiken RL, Lebovitz HE. Long-term normoglycemic remission in black newly diagnosed NIDDM subjects. Diabetes 1996;45:337-41. (Pubitemid 26069048)
21. Balasubramanyam A, Garza G, Rodriguez L, Hampe CS, Gaur L, Lernmark A, et al. Accuracy and predictive value of classification schemes for ketosis-prone diabetes. Diabetes Care 2006;29:2575-9. (Pubitemid 44912181)
22. Jones AG, Hattersley AT. The clinical utility of C-peptide measurement in the care of patients with diabetes. Diabet Med 2013; published online Feb 18.